# Intraperitoneal and Appendiceal Malignancies

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the management of peritoneal carcinomatosis from digestive tract cancers, particularly colorectal cancer and gastric cancer. It includes studies on cytoreductive surgery, intraperitoneal chemotherapy, hyperthermic intraperitoneal chemotherapy, and survival analysis in patients with peritoneal metastases. The cluster also covers topics such as pseudomyxoma peritonei, appendiceal neoplasms, and the treatment of peritoneal surface malignancy. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t12064 |
| Works | 219 |

## Topic papers all

Showing 15 of 219.

- [Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer](https://scholariq.org/papers/intraperitoneal-cisplatin-and-paclitaxel-in-ovarian-cancer/)
- [A Phase 3 Trial of Bevacizumab in Ovarian Cancer](https://scholariq.org/papers/a-phase-3-trial-of-bevacizumab-in-ovarian-cancer/)
- [Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study](https://scholariq.org/papers/phase-iii-trial-of-carboplatin-and-paclitaxel-compared-with-cisplatin-and/)
- [Diagnosis and treatment of acute appendicitis: 2020 update of the WSES Jerusalem guidelines](https://scholariq.org/papers/diagnosis-and-treatment-of-acute-appendicitis-2020-update-of-the-wses-jerusalem/)
- [OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer](https://scholariq.org/papers/oceans-a-randomized-double-blind-placebo-controlled-phase-iii-trial-of/)
- [Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial](https://scholariq.org/papers/paclitaxel-plus-platinum-based-chemotherapy-versus-conventional-platinum-based/)
- [Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/newly-diagnosed-and-relapsed-epithelial-ovarian-carcinoma-esmo-clinical-practice/)
- [Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study](https://scholariq.org/papers/phase-ii-trial-of-bevacizumab-in-persistent-or-recurrent-epithelial-ovarian/)
- [A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass](https://scholariq.org/papers/a-novel-multiple-marker-bioassay-utilizing-he4-and-ca125-for-the-prediction-of/)
- [Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial](https://scholariq.org/papers/standard-chemotherapy-with-or-without-bevacizumab-for-women-with-newly-diagnosed/)
- [Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-selective-internal-radiotherapy-with-yttrium-90-resin/)
- [Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis](https://scholariq.org/papers/rates-and-patterns-of-recurrence-following-curative-intent-surgery-for/)
- [Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer](https://scholariq.org/papers/phase-ii-study-of-bevacizumab-in-patients-with-platinum-resistant-ovarian-cancer/)
- [Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/ovarian-cancer-version-2-2020-nccn-clinical-practice-guidelines-in-oncology/)
- [Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup](https://scholariq.org/papers/evaluation-of-new-platinum-based-treatment-regimens-in-advanced-stage-ovarian/)

## Topic primary papers

Showing 15 of 52.

- [Peritoneal carcinomatosis of gastric origin: A population‐based study on incidence, survival and risk factors](https://scholariq.org/papers/peritoneal-carcinomatosis-of-gastric-origin-a-population-based-study-on/)
- [Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841](https://scholariq.org/papers/treatment-of-colorectal-peritoneal-carcinomatosis-with-systemic-chemotherapy-a/)
- [Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer](https://scholariq.org/papers/development-and-validation-of-an-individualized-nomogram-to-identify-occult/)
- [Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement](https://scholariq.org/papers/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-in-the/)
- [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial](https://scholariq.org/papers/adjuvant-hyperthermic-intraperitoneal-chemotherapy-in-patients-with-locally/)
- [ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)](https://scholariq.org/papers/enets-consensus-guidelines-for-neuroendocrine-neoplasms-of-the-appendix/)
- [Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol](https://scholariq.org/papers/cytoreduction-and-hipec-in-the-netherlands-nationwide-long-term-outcome/)
- [Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial](https://scholariq.org/papers/impact-of-maximal-cytoreductive-surgery-plus-regional-heated-intraperitoneal/)
- [Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States](https://scholariq.org/papers/consensus-guidelines-from-the-american-society-of-peritoneal-surface/)
- [Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy](https://scholariq.org/papers/medium-throughput-drug-screening-of-patient-derived-organoids-from-colorectal/)
- [The American Society of Colon and Rectal Surgeons, Clinical Practice Guidelines for the Management of Appendiceal Neoplasms](https://scholariq.org/papers/the-american-society-of-colon-and-rectal-surgeons-clinical-practice-guidelines-2/)
- [Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Chemoresistant and Recurrent Advanced Epithelial Ovarian Cancer: Prospective Study of 81 Patients](https://scholariq.org/papers/cytoreductive-surgery-and-intraperitoneal-chemohyperthermia-for-chemoresistant/)
- [Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial](https://scholariq.org/papers/adjuvant-hyperthermic-intraperitoneal-chemotherapy-hipec-in-patients-with-colon/)
- [Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study](https://scholariq.org/papers/secondary-cytoreduction-and-carboplatin-hyperthermic-intraperitoneal/)
- [Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin](https://scholariq.org/papers/genome-wide-mutational-landscape-of-mucinous-carcinomatosis-peritonei-of/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.